tiprankstipranks
Trending News
More News >
Fusen Pharmaceutical Co., Ltd. (HK:1652)
:1652
Hong Kong Market

Fusen Pharmaceutical Co., Ltd. (1652) Income Statement

Compare
0 Followers

Fusen Pharmaceutical Co., Ltd. Income Statement

Last quarter (Q4 2024), Fusen Pharmaceutical Co., Ltd.'s total revenue was ¥129.71M, a decrease of -60.23% from the same quarter last year. In Q4, Fusen Pharmaceutical Co., Ltd.'s net income was ¥-151.84M. See Fusen Pharmaceutical Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 326.03M¥ 565.61M¥ 491.76M¥ 385.66M¥ 486.85M
Gross Profit
¥ 162.64M¥ 299.51M¥ 225.02M¥ 211.13M¥ 266.07M
Operating Expenses
¥ 230.15M¥ 279.49M¥ 186.41M¥ 146.65M¥ 181.83M
Depreciation and Amortization
¥ 28.10M¥ 35.80M¥ 34.16M¥ 23.79M¥ 22.46M
EBITDA
¥ -39.07M¥ 18.93M¥ 49.90M¥ 55.82M¥ 110.30M
Operating Income
¥ -67.51M¥ 20.02M¥ 15.74M¥ 52.14M¥ 103.22M
Other Income/Expenses
¥ -122.94M¥ -49.46M¥ -74.75M¥ -28.35M¥ -24.81M
Pretax Income
¥ -190.45M¥ -29.45M¥ -30.99M¥ 23.79M¥ 78.41M
Net Income
¥ -188.78M¥ -36.28M¥ -34.65M¥ 16.64M¥ 70.13M
Per Share Metrics
Basic EPS
¥ -0.26¥ -0.05¥ -0.05¥ 0.02¥ 0.09
Diluted EPS
¥ -0.26¥ -0.05¥ -0.05¥ 0.02¥ 0.09
Weighted Average Shares Outstanding
739.98M 725.54M 756.07M 769.62M 786.08M
Weighted Average Shares Outstanding (Diluted)
739.98M 752.06M 756.07M 770.31M 790.16M
Currency in CNY

Fusen Pharmaceutical Co., Ltd. Earnings and Revenue History